Experimental drug targets cancers associated with Epstein-Barr virus
An experimental drug is reported to have potential to treat…
An experimental drug is reported to have potential to treat Epstein-Barr virus related lymphomas by counteracting the cancer-promoting mechanisms of LMP2A...